Results

Total Results: 1,147 records

Showing results for "event".

  1. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/tobacco-smoking-cessation-in-adults-including-pregnant-women-interventions
    March 15, 2018 - in progress Draft Research Plan Interventions for Tobacco Smoking Cessation in Adults, Including Pregnant Persons March 15, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.…
  2. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/prevention-of-human-immunodeficiency-virus-hiv-infection-pre-exposure-prophylaxis-june-2019
    July 26, 2017 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan Prevention of Human Immunodeficiency Virus (HIV) Infection: Preexposure Prophylaxis July 26, 2017 Recommendations made by the USPSTF are indep…
  3. www.uspreventiveservicestaskforce.org/uspstf/recommendation/depression-in-children-and-adolescents-screening-2009
    March 15, 2009 - comorbid mental health or chronic medical conditions, and having experienced a major negative life event … comorbid mental health or chronic medical conditions, and having experienced a major negative life event
  4. www.uspreventiveservicestaskforce.org/uspstf/recommendation/osteoporosis-screening-june-2018
    June 26, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Osteoporosis to Prevent Fractures: Screening June 26, 2018 Recommendations made by the USPSTF are independent of the U.S. gover…
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/4KRE4cPgK7ePRf9oq28vTd
    October 11, 2022 - Comparable intensity of therapy in study groups, coupled with low event rates for some outcomes (such
  6. www.uspreventiveservicestaskforce.org/uspstf/announcements/us-preventive-services-task-force-issues-final-evidence-report-screening-coronary-heart-disease-electrocardiography
    September 21, 2011 - U.S. Preventive Services Task Force Issues Final Evidence Report for Screening for Coronary Heart Disease With Electrocardiography Share to Facebook Share to X Share to WhatsApp Share to Email Print September 21, 2011 – In order to update its…
  7. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening
    June 26, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence Summary Osteoporosis to Prevent Fractures: Screening June 26, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should not be con…
  8. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary1/osteoporosis-screening-june-2018
    June 26, 2018 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Evidence Summary Osteoporosis to Prevent Fractures: Screening June 26, 2018 Recommendations made by the USPSTF are independent of the U.S. government. They should…
  9. www.uspreventiveservicestaskforce.org/uspstf/recommendation/peripheral-arterial-disease-pad-screening
    August 08, 2005 - archived Final Recommendation Statement Peripheral Arterial Disease (PAD): Screening August 08, 2005 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Departme…
  10. www.uspreventiveservicestaskforce.org/home/getfilebytoken/a_x9VThjBWewPwLWsUkVav
    January 01, 2015 - no difference between treatment with vitamin D and placebo or no treatment in risk for any adverse event
  11. www.uspreventiveservicestaskforce.org/home/getfilebytoken/_SBmXPhUQWo-dc85FJ5wHf
    February 01, 2015 - Diagnostic and Predictive Accuracy of Blood Pressure Screening Methods With Consideration of Rescreening Intervals: A Systematic Review for the U.S. Preventive Services Task Force Margaret A. Piper, PhD, MPH; Corinne V. Evans, MPP; Brittany U. Burda, MPH; Karen L. Margolis, MD, MPH; Elizabeth O’Connor, PhD; and Evelyn …
  12. www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/glaucoma-screening-adults-older-adults
    October 26, 2021 - due to adverse events (RR, 2.40, [95% CI, 0.71 to 19.32]; I 2 =0%; 5 trials; n=648), or any adverse event
  13. www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/primary-angle-glaucoma-screening
    October 26, 2021 - due to adverse events (RR, 2.40, [95% CI, 0.71 to 19.32]; I 2 =0%; 5 trials; n=648), or any adverse event
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/9AtjNaSwTXonz49w_DEbNz
    November 07, 2023 - re- ported 12 of 1473 children assigned to varnish reported adverse events (the most common adverse event … events and 1 trial reported 0.04% of children allocated to varnish reported a self-limited adverse event
  15. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/breast-cancer-screening
    April 30, 2024 - Twenty-seven participants (0.6% of the MRI group) reported a serious adverse event within 30 days of
  16. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/colorectal-cancer-screening3
    January 03, 2019 - in progress Draft Research Plan Screening for Colorectal Cancer January 03, 2019 Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Se…
  17. www.uspreventiveservicestaskforce.org/uspstf/document/routine-vitamin-supplementation-to-prevent-cancer-update-of-the-evidence-from-randomized-controlled-trials-19992002/vitamin-supplementation-to-prevent-cancer-and-cvd-counseling-and-preventive-medication-2003
    June 15, 2003 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Routine Vitamin Supplementation to Prevent Cancer: Update of the Evidence from Randomized Controlled Trials 1999-2002* Vitamin Supplementation to Prevent Cancer and CVD: C…
  18. www.uspreventiveservicestaskforce.org/home/getfilebytoken/boPWHmzrtxnkkPQAoCNENS
    September 18, 2018 - For harms, RCTs, systematic reviews, and large cohort, case-control, or event-monitoring studies were … Safety profile of orlistat: results of a prescription-event monitoring study.
  19. www.uspreventiveservicestaskforce.org/home/getfilebytoken/WEqCV3NvnZAeLdC_pp6nVK
    October 01, 2018 - Supplement).13,14,16,17 DAA regi- mens were associated with slightly increased risk of any adverse event … Pooled Adverse Event Rates for DAA Regimens | DAA therapy was fre- quently associated with experiencing … any adverse event (44 trials, n = 8045; 73.3% [95% CI, 68.0% to 78.1%]; I2 = 95%) (eFigure 4 in the … Adverse event estimates were generally similar when studies were stratified according to baseline cirrhosis … HCV genotypes, low rates of serious adverse events and treatment discontinuation, and higher adverse event
  20. www.uspreventiveservicestaskforce.org/uspstf/draft-recommendation/prediabetes-and-type-2-diabetes-mellitus-screening
    March 16, 2021 - risk of all-cause mortality, cardiovascular-related mortality, occurrence of a first cardiovascular event

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: